7 Evecare • Vol 11 • No. 2 • Sep–Dec 2023 Product Profile Evecare forteTM (LIQUID, TABLET) For the effective management of PCOS Introduction Evecare forte Liquid is a phytopharmaceutical formulation recommended for the comprehensive management of polycystic ovary syndrome (PCOS). Composition Each 5 mL of Evecare forte Liquid contains: Extracts Lodhra (Symplocos racemosa) 41.25 mg Methi (Trigonella foenum-graecum) 40.22 mg Mundi (Sphaeranthus indicus) 18.57 mg Jatamansi (Nardostachys jatamansi) 8.59 mg Powder Kanyasaara (Aloe barbadensis) 3.87 mg Each Evecare forte Tablet contains: Extracts Lodhra (S racemosa) 165.00 mg Methi (T foenum-graecum) 160.89 mg Mundi (S indicus) 74.26 mg Jatamansi (N jatamansi) 34.38 mg Powder Kanyasaara (A barbadensis) 15.47 mg Clinical Pharmacology Evecare forte Liquid is a safe, polyherbal, and nonhormonal menstrual modulator for the effective and comprehensive management of PCOS. Evecare forte Liquid helps regularize endogenous hormonal status, correct the cyclical rhythm, and reduce the number of abnormal ovarian follicles. It improves ovulatory function and other metabolic derangements associated with insulin resistance through its insulin-sensitizing activity. Evecare forte Liquid helps regularize the menstrual cycle and corrects symptoms of hyperandrogenism such as hirsutism and hyperpigmentation. Further, it improves the chances of fertility and also helps reduce mood swings, anxiety, and depression associated with PCOS. Indication PCOS Dosage Liquid: 10 to 20 mL, twice daily, for 3 to 6 months, or as directed by the physician. Tablet: 1 tablet twice daily, or as directed by the physician. Adverse Effects No adverse effects have been reported. Contraindications No known contraindications. Special Precautions To be used with caution in individuals with estrogendependent tumors. Drug Interactions No clinically significant drug interactions have been reported.
RkJQdWJsaXNoZXIy MjAwNDg=